Joana is currently completing her PhD in Biomedicine and Clinical Research at Universidade de Lisboa. She also holds a BSc in Biology and an MSc in Evolutionary and Developmental Biology from Universidade de Lisboa. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that make up the lining of blood vessels — found in the umbilical cord of newborns.
Autoantibodies targeting certain regulatory RNAs — molecules that serve as the template for protein production — in the brains of lupus patients are unique to these people and involved in neuropsychiatric ... Read more
Gazyva (obinutuzumab) in combination with standard-of-care agents significantly increases the percentage of patients with proliferative lupus nephritis achieving complete or partial renal response, top-line data from a Phase 2 ... Read more
The U.S. Food and Drug Administration (FDA) has approved, under priority review, the use of Benlysta (belimumab) for the treatment of children age 5 and older with systemic lupus erythematosus (SLE). ... Read more
The Lupus Research Alliance (LRA) has funded a series of research projects, ongoing worldwide, aimed at seeking new therapies for people with lupus. The award recipients presented their findings ... Read more
A frailty index developed by the Systemic Lupus International Collaborating Clinics (SLICC) could be a powerful and meaningful health measure to estimate vulnerability and mortality risk among patients with systemic lupus erythematosus ... Read more
Systemic lupus erythematosus (SLE) patients have a higher risk for certain cancers — including cervical, thyroid, ovarian, and oral cancer, as well as lymphoma, multiple myeloma, and leukemia — ... Read more
Pin It on Pinterest